Cargando…

A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents

OBJECTIVE: To investigate injection site pain (ISP) and other injection site outcomes caused by biologics administered alongside citrate-free (CF) and citrate-containing (CC) formulations. METHODS: Electronic literature databases (Medline, Embase, and Cochrane Library) were systematically searched f...

Descripción completa

Detalles Bibliográficos
Autores principales: Junker, Sophia, Ebert, Oliver, Bartsch, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433360/
https://www.ncbi.nlm.nih.gov/pubmed/36043729
http://dx.doi.org/10.2174/1573397118666220829123713
_version_ 1785091633120804864
author Junker, Sophia
Ebert, Oliver
Bartsch, Robert
author_facet Junker, Sophia
Ebert, Oliver
Bartsch, Robert
author_sort Junker, Sophia
collection PubMed
description OBJECTIVE: To investigate injection site pain (ISP) and other injection site outcomes caused by biologics administered alongside citrate-free (CF) and citrate-containing (CC) formulations. METHODS: Electronic literature databases (Medline, Embase, and Cochrane Library) were systematically searched for clinical trials and observational studies reporting on injection site outcomes after subcutaneous administration of biologics. Studies with unknown excipient formulations were excluded. The primary outcome was ISP, and secondary outcomes included any other reported injection site reactions (ISRs). Meta-analysis approaches were used to aggregate evidence identified via the conducted systematic literature review. RESULTS: A total of two observational studies, two cross-over/sequential trials, and three head-to-head comparison trials directly comparing CF with CC biologics were identified, as well as seven placebo-controlled trials. Evidence from five of the seven direct comparison studies suggested reduced pain perception at the injection site when CF formulations were applied. Findings for other ISRs were balanced between both formulations, with slightly favorable results for preparations without citrate. A meta-analysis of placebo-controlled trials found no significant difference between arms with CF formulations and placebo regarding the proportion of patients experiencing ISP (OR 0.62, 95% CI 0.30-1.28). CONCLUSION: Excipient formulations are rarely specified in studies assessing pain and other ISRs of subcutaneously administered biologics. The available data indicate that subcutaneous administration of biologic agents without citrate may be associated with lower pain perception outcomes compared with treatment using CC formulations. Importantly, ISP is influenced by many factors which may have affected the results. More research is needed to assess how formulation excipients influence ISRs.
format Online
Article
Text
id pubmed-10433360
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-104333602023-08-18 A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents Junker, Sophia Ebert, Oliver Bartsch, Robert Curr Rheumatol Rev Medicine, Rheumatology OBJECTIVE: To investigate injection site pain (ISP) and other injection site outcomes caused by biologics administered alongside citrate-free (CF) and citrate-containing (CC) formulations. METHODS: Electronic literature databases (Medline, Embase, and Cochrane Library) were systematically searched for clinical trials and observational studies reporting on injection site outcomes after subcutaneous administration of biologics. Studies with unknown excipient formulations were excluded. The primary outcome was ISP, and secondary outcomes included any other reported injection site reactions (ISRs). Meta-analysis approaches were used to aggregate evidence identified via the conducted systematic literature review. RESULTS: A total of two observational studies, two cross-over/sequential trials, and three head-to-head comparison trials directly comparing CF with CC biologics were identified, as well as seven placebo-controlled trials. Evidence from five of the seven direct comparison studies suggested reduced pain perception at the injection site when CF formulations were applied. Findings for other ISRs were balanced between both formulations, with slightly favorable results for preparations without citrate. A meta-analysis of placebo-controlled trials found no significant difference between arms with CF formulations and placebo regarding the proportion of patients experiencing ISP (OR 0.62, 95% CI 0.30-1.28). CONCLUSION: Excipient formulations are rarely specified in studies assessing pain and other ISRs of subcutaneously administered biologics. The available data indicate that subcutaneous administration of biologic agents without citrate may be associated with lower pain perception outcomes compared with treatment using CC formulations. Importantly, ISP is influenced by many factors which may have affected the results. More research is needed to assess how formulation excipients influence ISRs. Bentham Science Publishers 2023-06-05 2023-06-05 /pmc/articles/PMC10433360/ /pubmed/36043729 http://dx.doi.org/10.2174/1573397118666220829123713 Text en © 2023 Bentham Science Publishers https://creativecommons.org/licenses/by/4.0/© 2023 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
spellingShingle Medicine, Rheumatology
Junker, Sophia
Ebert, Oliver
Bartsch, Robert
A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents
title A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents
title_full A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents
title_fullStr A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents
title_full_unstemmed A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents
title_short A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents
title_sort systematic literature review of injection site pain perception in adult patients treated with citrate-free and citrate-containing biologic agents
topic Medicine, Rheumatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433360/
https://www.ncbi.nlm.nih.gov/pubmed/36043729
http://dx.doi.org/10.2174/1573397118666220829123713
work_keys_str_mv AT junkersophia asystematicliteraturereviewofinjectionsitepainperceptioninadultpatientstreatedwithcitratefreeandcitratecontainingbiologicagents
AT ebertoliver asystematicliteraturereviewofinjectionsitepainperceptioninadultpatientstreatedwithcitratefreeandcitratecontainingbiologicagents
AT bartschrobert asystematicliteraturereviewofinjectionsitepainperceptioninadultpatientstreatedwithcitratefreeandcitratecontainingbiologicagents
AT junkersophia systematicliteraturereviewofinjectionsitepainperceptioninadultpatientstreatedwithcitratefreeandcitratecontainingbiologicagents
AT ebertoliver systematicliteraturereviewofinjectionsitepainperceptioninadultpatientstreatedwithcitratefreeandcitratecontainingbiologicagents
AT bartschrobert systematicliteraturereviewofinjectionsitepainperceptioninadultpatientstreatedwithcitratefreeandcitratecontainingbiologicagents